Overlooked Alpha

Overlooked Alpha

Share this post

Overlooked Alpha
Overlooked Alpha
A Nutrition Play with 30% EBITDA Margins and a Massive Opportunity
Copy link
Facebook
Email
Notes
More

A Nutrition Play with 30% EBITDA Margins and a Massive Opportunity

Overlooked Alpha
Feb 06, 2025
∙ Paid
12

Share this post

Overlooked Alpha
Overlooked Alpha
A Nutrition Play with 30% EBITDA Margins and a Massive Opportunity
Copy link
Facebook
Email
Notes
More
Share

This UK small cap produces fitness, health and nutritional products. The company listed on the London Stock Exchange last October via IPO which valued the firm at approximately £350M. Revenue has tripled in the last three years while the company reports healthy margins and strong cash flow generation. We think the company's position in the expanding health and wellness market, combined with its strong operational execution, makes for a compelling investment case. Currently, the stock appears to be flying under the radar of many investors, suggesting potential for share price appreciation as market awareness grows. Let's dig in…

Business Overview

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Joe Marwood
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More